Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors

Bioconjugate Chemistry

Volumn 22, Issue 7, 2011, Pages 1374-1385

  Alshoukr, Faisal ^a,b,c   Prignon, Aurélie ^d   Brans, Luc ^e   Jallane, Abdelhak ^a,b,c   Mendes, Sandra ^a,b,c   Talbot, Jean Noël ^d   Tourwé, Dirk ^e   Barbet, Jacques ^c,f   Gruaz Guyon, Anne ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DIAGNOSIS; DISEASES; MEDICAL IMAGING; NUCLEAR MEDICINE; PEPTIDES; STABILITY; TUMORS;

HIGH AFFINITY; HT-29 CELLS; NEUROTENSIN; OVEREXPRESSIONS; PEPTIDE SEQUENCES; RECEPTOR-1; SEQUENCE MODIFICATION; TIME POINTS; TOMOGRAPHY IMAGING; TUMOR UPTAKE;

POSITRON EMISSION TOMOGRAPHY;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7 TRIS(ACETIC ACID) 10 ACETIC ACID MONO(N HYDROXYSUCCINIMIDYL ESTER); 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID GA 68; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID LB 119 GA 68; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID LU 177; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID NEUROTENSIN 20.3 GA 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID NEUROTENSIN 20.3 GA 69; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID NEUROTENSIN 20.3 IN 111; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID Y 90; ARGININE; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; INDIUM 111; LUTETIUM 177; NEUROTENSIN RECEPTOR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; UNCLASSIFIED DRUG; YTTRIUM 90;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL STRAIN HT29; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY TUBULE ABSORPTION; MALE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROTEIN BINDING; SCINTIGRAPHY;

MUS;

EID: 79960615907     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc200078p     Document Type: Article

References (46)

1. Myers, R. M., Shearman, J. W., Kitching, M. O., Ramos-Montoya, A., Neal, D. E., and Ley, S. V. (2009) Cancer, chemistry, and the cell: molecules that interact with the neurotensin receptors ACS Chem. Biol. 4, 503-525
2. Vincent, J. P., Mazella, J., and Kitabgi, P. (1999) Neurotensin and neurotensin receptors Trends Pharmacol. Sci. 20, 302-309 (Pubitemid 29301684)
3. Evers, B. M. (2006) Neurotensin and growth of normal and neoplastic tissues Peptides 27, 2424-2433
4. Thomas, R. P., Hellmich, M. R., Townsend, C. M., Jr., and Evers, B. M. (2003) Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues Endocr. Rev. 24, 571-599 (Pubitemid 37330583)
5. Ehlers, R. A., Kim, S., Zhang, Y., Ethridge, R. T., Murrilo, C., Hellmich, M. R., Evans, D. B., Townsend, C. M., Jr., and Mark Evers, B. (2000) Gut peptide receptor expression in human pancreatic cancers Ann. Surg. 231, 838-848 (Pubitemid 30350242)
6. Reubi, J. C., Waser, B., Friess, H., Buchler, M., and Laissue, J. (1998) Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma Gut 42, 546-550 (Pubitemid 28186573)
7. Souaze, F., Dupouy, S., Viardot-Foucault, V., Bruyneel, E., Attoub, S., Gespach, C., Gompel, A., and Forgez, P. (2006) Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression Cancer Res. 66, 6243-6249
8. Alifano, M., Souaze, F., Dupouy, S., Camilleri-Broet, S., Younes, M., Ahmed-Zaid, S. M., Takahashi, T., Cancellieri, A., Damiani, S., Boaron, M., Broet, P., Miller, L. D., Gespach, C., Regnard, J. F., and Forgez, P. (2010) Neurotensin receptor 1 determines the outcome of non-small cell lung cancer Clin. Cancer Res. 16, 4401-4410
9. Alifano, M., Loi, M., Camilleri-Broet, S., Dupouy, S., Regnard, J. F., and Forgez, P. (2010) Neurotensin expression and outcome of malignant pleural mesothelioma Biochimie 92, 164-170
10. Gui, X., Guzman, G., Dobner, P. R., and Kadkol, S. S. (2008) Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma Peptides 29, 1609-1615
11. Shimizu, S., Tsukada, J., Sugimoto, T., Kikkawa, N., Sasaki, K., Chazono, H., Hanazawa, T., Okamoto, Y., and Seki, N. (2008) Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway Int. J. Cancer 123, 1816-1823
12. Swift, S. L., Burns, J. E., and Maitland, N. J. (2010) Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer Cancer Res. 70, 347-356
13. Reubi, J. C., Waser, B., Schaer, J. C., and Laissue, J. A. (1999) Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas Int. J. Cancer 82, 213-218 (Pubitemid 29293780)
14. Dupouy, S., Viardot-Foucault, V., Alifano, M., Souaze, F., Plu-Bureau, G., Chaouat, M., Lavaur, A., Hugol, D., Gespach, C., Gompel, A., and Forgez, P. (2009) The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression PLoS One 4, e4223
15. Kwekkeboom, D. J., Kam, B. L., van Essen, M., Teunissen, J. J., van Eijck, C. H., Valkema, R., de Jong, M., de Herder, W. W., and Krenning, E. P. (2010) Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors Endocr. Relat. Cancer 17, R53-73
16. Krenning, E. P., Teunissen, J. J., Valkema, R., deHerder, W. W., deJong, M., and Kwekkeboom, D. J. (2005) Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors J. Endocrinol. Invest. 28, 146-150
17. Granier, C., van Rietschoten, J., Kitabgi, P., Poustis, C., and Freychet, P. (1982) Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8 - 13) is the shortest analogue with full binding and pharmacological activities Eur. J. Biochem. 124, 117-124 (Pubitemid 12094720)
18. Hillairet De Boisferon, M., Raguin, O., Thiercelin, C., Dussaillant, M., Rostene, W., Barbet, J., Pelegrin, A., and Gruaz-Guyon, A. (2002) Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model Bioconjugate Chem. 13, 654-662 (Pubitemid 34527529)
19. Alshoukr, F., Rosant, C., Maes, V., Abdelhak, J., Raguin, O., Burg, S., Sarda, L., Barbet, J., Tourwe, D., Pelaprat, D., and Gruaz-Guyon, A. (2009) Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors Bioconjugate Chem. 20, 1602-1610
20. Maecke, H. R., Hofmann, M., and Haberkorn, U. (2005) (68)Ga-labeled peptides in tumor imaging J. Nucl. Med. 46 (Suppl 1) 172S-178S
21. Wei, L., Zhang, X., Gallazzi, F., Miao, Y., Jin, X., Brechbiel, M. W., Xu, H., Clifford, T., Welch, M. J., Lewis, J. S., and Quinn, T. P. (2009) Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A″- Re(Arg11)CCMSH Nucl. Med. Biol. 36, 345-354
22. Mansi, R., Wang, X., Forrer, F., Kneifel, S., Tamma, M. L., Waser, B., Cescato, R., Reubi, J. C., and Maecke, H. R. (2009) Evaluation of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated bombesin-based radioantagonist for the labeling with single-photon emission computed tomography, positron emission tomography, and therapeutic radionuclides Clin. Cancer Res. 15, 5240-5249
23. Pagou, M., Zerizer, I., and Al-Nahhas, A. (2009) Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging? Hell. J. Nucl. Med. 12, 102-105
24. Buchmann, I., Henze, M., Engelbrecht, S., Eisenhut, M., Runz, A., Schafer, M., Schilling, T., Haufe, S., Herrmann, T., and Haberkorn, U. (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours Eur. J. Nucl. Med. Mol. Imaging 34, 1617-1626 (Pubitemid 47476920)
25. Hofmann, M., Maecke, H., Borner, R., Weckesser, E., Schoffski, P., Oei, L., Schumacher, J., Henze, M., Heppeler, A., Meyer, J., and Knapp, H. (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data Eur. J. Nucl. Med. 28, 1751-1757
26. Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., and Virgolini, I. J. (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT J. Nucl. Med. 48, 508-518 (Pubitemid 47571404)
27. Kowalski, J., Henze, M., Schuhmacher, J., Macke, H. R., Hofmann, M., and Haberkorn, U. (2003) Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors Mol. Imaging Biol. 5, 42-48 (Pubitemid 36596544)
28. Liu, S. (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides Adv. Drug Delivery Rev. 60, 1347-1370
29. Wang, D., Miller, S. C., Sima, M., Parker, D., Buswell, H., Goodrich, K. C., Kopeckova, P., and Kopecek, J. (2004) The arthrotropism of macromolecules in adjuvant-induced arthritis rat model: a preliminary study Pharm. Res. 21, 1741-1749 (Pubitemid 39390083)
30. Brans, L., Maes, V., Garcia-Garayoa, E., Schweinsberg, C., Daepp, S., Blauenstein, P., Schubiger, P. A., Schibli, R., and Tourwe, D. A. (2008) Glycation methods for bombesin analogs containing the (NalphaHis)Ac chelator for 99mTc(CO)3 radiolabeling Chem. Biol. Drug Des. 72, 496-506
31. Raguin, O., Gruaz-Guyon, A., and Barbet, J. (2002) Equilibrium expert: an add-in to Microsoft Excel for multiple binding equilibrium simulations and parameter estimations Anal. Biochem. 310, 1-14 (Pubitemid 35387325)
32. Stefanovski, D., Moate, P. J., and Boston, R. C. (2003) WinSAAM: a windows-based compartmental modeling system Metabolism 52, 1153-1166 (Pubitemid 37203490)
33. Riches, A. C., Sharp, J. G., Thomas, D. B., and Smith, S. V. (1973) Blood volume determination in the mouse J. Physiol. 228, 279-284
34. Sung, C., Youle, R. J., and Dedrick, R. L. (1990) Pharmacokinetic analysis of immunotoxin uptake in solid tumors: role of plasma kinetics, capillary permeability, and binding Cancer Res. 50, 7382-7392
35. Covell, D. G., Barbet, J., Holton, O. D., Black, C. D., Parker, R. J., and Weinstein, J. N. (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab′)2, and Fab′ in mice Cancer Res. 46, 3969-3978 (Pubitemid 16075893)
36. Akizawa, H., Arano, Y., Mifune, M., Iwado, A., Saito, Y., Mukai, T., Uehara, T., Ono, M., Fujioka, Y., Ogawa, K., Kiso, Y., and Saji, H. (2001) Effect of molecular charges on renal uptake of 111In-DTPA-conjugated peptides Nucl. Med. Biol. 28, 761-768 (Pubitemid 32900633)
37. Froidevaux, S., Calame-Christe, M., Tanner, H., and Eberle, A. N. (2005) Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake J. Nucl. Med. 46, 887-895
38. Barroso, S., Richard, F., Nicolas-Etheve, D., Reversat, J. L., Bernassau, J. M., Kitabgi, P., and Labbe-Jullie, C. (2000) Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1 J. Biol. Chem. 275, 328-336 (Pubitemid 30038989)
39. Garcia-Garayoa, E., Blauenstein, P., Blanc, A., Maes, V., Tourwe, D., and Schubiger, P. A. (2009) A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours Eur. J. Nucl. Med. Mol. Imaging 36, 37-47
40. Maes, V., Garcia-Garayoa, E., Blauenstein, P., and Tourwe, D. (2006) Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties J. Med. Chem. 49, 1833-1836 (Pubitemid 43376527)
41. Achilefu, S., Srinivasan, A., Schmidt, M. A., Jimenez, H. N., Bugaj, J. E., and Erion, J. L. (2003) Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors J. Med. Chem. 46, 3403-3411 (Pubitemid 36842424)
42. de Visser, M., Janssen, P. J., Srinivasan, A., Reubi, J. C., Waser, B., Erion, J. L., Schmidt, M. A., Krenning, E. P., and de Jong, M. (2003) Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer Eur. J. Nucl. Med. Mol. Imaging 30, 1134-1139 (Pubitemid 36988225)
43. Froidevaux, S., Eberle, A. N., Christe, M., Sumanovski, L., Heppeler, A., Schmitt, J. S., Eisenwiener, K., Beglinger, C., and Macke, H. R. (2002) Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model Int. J. Cancer 98, 930-937 (Pubitemid 34286693)
44. Koumarianou, E., Mikolajczak, R., Pawlak, D., Zikos, X., Bouziotis, P., Garnuszek, P., Karczmarczyk, U., Maurin, M., and Archimandritis, S. C. (2009) Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation Nucl. Med. Biol. 36, 591-603
45. de Jong, M., Rolleman, E. J., Bernard, B. F., Visser, T. J., Bakker, W. H., Breeman, W. A., and Krenning, E. P. (1996) Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo J. Nucl. Med. 37, 1388-1392 (Pubitemid 26330680)
46. Vegt, E., van Eerd, J. E., Eek, A., Oyen, W. J., Wetzels, J. F., de Jong, M., Russel, F. G., Masereeuw, R., Gotthardt, M., and Boerman, O. C. (2008) Reducing renal uptake of radiolabeled peptides using albumin fragments J. Nucl. Med. 49, 1506-1511